VERTEX PRESENTS NEW DATA ON CASGEVY®, INCLUDING FIRST-EVER DATA IN CHILDREN AGES 5-11 YEARS, AT THE AMERICAN SOCIETY OF HEMATOLOGY ANNUAL MEETING AND ANNOUNCES PLAN FOR GLOBAL REGULATORY SUBMISSIONS

Reuters · 1d ago

Please log in to view news